Latest Market News

Mirrabooka Investments Limited has announced a fully franked ordinary dividend of AUD 0.045 per share for the half-year ending December 2025, offering shareholders reinvestment and bonus share plans without discounts.

ReNerve Limited has secured market approval for its NervAlign® Nerve Cuff in Malaysia, marking a key milestone in its Asia-Pacific expansion strategy. This approval follows earlier clearances in Hong Kong and Thailand, positioning the company to tap into a growing regional nerve repair market.

MyEco Group has reported a record quarter for its MyEcoBag® products, driven by strong Australian retail growth and poised to benefit from upcoming NSW organic waste regulations.

TechGen Metals Limited has unveiled a fully funded 2026 exploration program targeting copper, gold, and silver across four promising Australian projects, aiming to transform its portfolio with significant mineral discoveries.

Atomo Diagnostics has landed a significant $502,000 order for HIV self-tests destined for an African country, underscoring sustained demand for accessible diagnostics in the region.

Articore Group reports solid progress in its turnaround strategy, showing margin expansion and a slowing decline in marketplace revenue for 2QFY26 and 1HFY26.

Alcidion Group has been named preferred supplier for a major UK hospital's Electronic Patient Record system, driving a 40% jump in contracted revenue and a robust cash position in Q2 FY26.

Amaero Ltd has lowered its FY2026 revenue guidance due to delayed U.S. government contracts but reports strong contracted revenue and a robust cash position heading into 2026.

Vitrafy Life Sciences has entered a 12-month exclusive partnership with IMV Technologies to integrate cryopreservation technologies, securing up to A$930k in fees and milestone payments.

Vitrafy Life Sciences has secured a 12-month exclusive partnership with global animal reproduction leader IMV Technologies to co-develop and commercialise next-generation cryopreservation solutions for farm animals and aquaculture.

Aquirian Limited reports a robust first half of FY26 with revenue up 27.4% and EBITDA more than doubling, driven by strategic facility upgrades and promising joint ventures.

Osteopore Limited has completed the full subscription of Tranche 1 under its A$20 million convertible notes facility, raising an additional A$250,000 to support ongoing business and future projects.